Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NurOwn in progressive MS
NCT03799718Phase 2Completed
- Sponsor
- BrainStorm Cell Therapeutics Inc.
- Start
- Mar 2019
- Primary completion
- Mar 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MSC-NTF in multiple sclerosis (MS), sponsored by BrainStorm Cell Therapeutics Inc.. Started Mar 2019; status: completed.
02
Drugs
MSC-NTF
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03799718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799718.